Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis

Hong, N; Shin, S; Lee, S; Rhee, Y

Rhee, Y (通讯作者)，Yonsei Univ, Coll Med, Endocrine Res Inst, Div Endocrinol,Dept Internal Med, Seoul 03722, South Korea.

OSTEOPOROSIS INTERNATIONAL, 2023; 34 (12): 2059

Abstract

Mini abstractIn this study, romosozumab demonstrated significantly greater improvement in trabecular bone score compared to denosumab therapy in postm......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索